# RESTORIL
> **NDA018163** · New Drug Application · Sponsor: SPECGX LLC · Approved 1981-02-27
## Drug
- **FDA Application Number:** NDA018163
- **Application type:** New Drug Application
- **Brand name:** RESTORIL
- **Generic name:** TEMAZEPAM
- **Active ingredients:** TEMAZEPAM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SPECGX LLC
- **Manufacturer:** SpecGx LLC
- **First approval:** 1981-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018163)
---
*AI Analytics · CC0 1.0*